Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C108192
http://purl.bioontology.org/ontology/MESH/C108192
|
|---|---|
| Preferred Name | aloxistatin |
| Synonyms |
(2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester
epoxysuccinyl-leucylamide(3-methyl)butane ethyl ester
EP-453
EP 453
loxistatin, (2S-(2alpha,3beta(R*)))-isomer
ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate
E64d inhibitor
ethyl epoxysuccinyl-leucylamido-3-methylbutane
loxistatin
protease inhibitor E64d
ethyl 3-(3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl)-2-oxiranecarboxylate
See more
See less
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel |
(2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester
epoxysuccinyl-leucylamide(3-methyl)butane ethyl ester
EP-453
EP 453
loxistatin, (2S-(2alpha,3beta(R*)))-isomer
ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate
E64d inhibitor
ethyl epoxysuccinyl-leucylamido-3-methylbutane
loxistatin
protease inhibitor E64d
ethyl 3-(3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl)-2-oxiranecarboxylate
See more
See less
|
|---|---|
| prefLabel | aloxistatin
|
| Scope Statement | a membrane-permeable cysteine protease inhibitor
|
| type | |
| isa | |
| PA |
D010975
D015853
|
| tui |
T116
T121
|
| Has mapping qualifier | |
| HM | D007930/Q000031
|
| SC | 1
|
| TERMUI |
T585354
T167445
T585356
T311167
T167451
T167446
T585357
T167448
T585355
T352622
T585353
T167449
See more
See less
|
| TH |
NLM (1997)
NLM (2004)
FDA SRS (2013)
INN (19XX)
|
| SRC | Metabolism 1997 Sep;46(9):1090-4
|
| MMR | 20121105
|
| notation | C108192
|
| Semantic type UMLS property | |
| RR |
96244-68-7
88321-09-9 (aloxistatin)
|
| cui |
C0665866
C0116283
C0902566
|
| MeSH Frequency | 131
|
| DSC | 19971002
|
| Inverse of RB |
96244-68-7
L5W337AOUR
0
|
| Mapped to | |
| MDA | 19971002
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |